About
LeonaBio develops novel small molecule therapies, including lasofoxifene and brelgometon, targeting diseases with limited current treatment options through clinical trials evaluating their safety and efficacy.
Explore LeonaBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.